Imovax Polio

Description

Imovax Polio is an Inactivated Poliomyelitis Vaccine containing 3 Types of Polioviruses which cause Polio.

IMMUNIZATION GUIDELINE

Primary vaccination:

• From 2 months of age, 3 successive injections of 0.5 ml should be administered at intervals of one or two months

• From 6 weeks of age, IMOVAX POLIO may be administered following the 6, 10, 14-week schedule, as per the recommendations of the Expanded Programme on Immunisation of the World Health Organisation.

Booster:

• In children in the second year of life, a 4th dose (1st booster) is administered one year after the 3rd injection. A booster is given every 5 years in children

For latest IAP updates see revised immunization schedule.

vaccine-type

Polio vaccine – injectable

manufacturer

Sanofi Pasteur

country-of-manufacture

France

pharmaceutical-form

Liquid

package-size

10 Dose

route-of-administration

Intramuscular, Subcutaneous

preservative

Phenoxyethanol,

Contraindications

Do not use IMOVAX POLIO if your child is allergic to the active substances, to one of the excipients, to neomycin, to streptomycin or to polymyxine B or have had an allergic reaction following a previous injection of this vaccine. Have a fever or acute illness; in this case, vaccination should be postponed.